Clinical Trials for Chronic Myeloid Leukemia, Chronic Phase

Find clinical trials for chronic myeloid leukemia, chronic phase. Discover research opportunities and treatment options in your area.

7 Active Trials Found

Showing 7 trials on this page

Page 1 of 1

Ponatinib in Chronic Myeloid Leukemia Patients in Chronic Phase

NCT ID: NCT06119269

This clinical trial is looking at how the drug ponatinib works in patients with chronic myeloid leukemia (CML) who are in the chronic phase of the disease. Researchers want to understand the relati...

Recruiting

Type: observational Locations: Cagliari, , Italy, Milano, , Italy +3 more

Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase

NCT ID: NCT05143840

This clinical trial is studying a medication called asciminib as a first treatment option for adults who have recently been diagnosed with Chronic Myeloid Leukemia (CML) in its chronic phase. The g...

Recruiting

Phase: PHASE2 Type: interventional Locations: Salt Lake City, Utah, United States, New York, New York, United States +4 more

PEARL Study: PotEntial of Asciminib in the eaRly Treatment of CML

NCT ID: NCT06409936

The PEARL Study is a clinical trial aimed at exploring the effectiveness and safety of a medication called asciminib for treating newly diagnosed patients with chronic myeloid leukemia (CML), speci...

Not yet recruiting

Phase: PHASE2 Type: interventional

CARDINAL- A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia

NCT ID: NCT06163430

The CARDINAL clinical trial is studying a new medication called TERN-701 to see how safe and effective it is for people with chronic myeloid leukemia (CML) who have already received treatment. The ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Adelaide, South Australia, Australia, Perth, Western Australia, Australia +41 more

A Phase 3 Study for the Efficacy and Safety of Radotinib in CP-CML Patients With Failure or Intolerance to Previous TKIs

NCT ID: NCT03459534

This clinical trial is studying a medication called Radotinib to see how effective and safe it is for patients with chronic phase chronic myeloid leukemia (CML) who have not responded well to or ha...

Recruiting

Phase: PHASE3 Type: interventional Locations: Ankara, , Turkey, Izmir, , Turkey +15 more

A Study of Treatment-free Remission in Chronic Phase Chronic Myeloid Leukemia

NCT ID: NCT06368414

This clinical trial is studying a new approach to help patients with chronic phase chronic myeloid leukemia (CML) achieve what is called treatment-free remission (TFR). This means the hope is that ...

Not yet recruiting

Phase: PHASE2 Type: interventional

Treatment With Olverembatinib in CML-CP Patients Who Failed to at Least Two Previously Administered Second-generation TKIs.

NCT ID: NCT05311943

This clinical trial is looking at a new treatment called olverembatinib for patients with chronic myeloid leukemia (CML) who are in the chronic phase and have not responded well or cannot tolerate ...

Recruiting

Phase: PHASE3 Type: interventional Locations: Shenzhen, Guangdong, China

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions